mitomycin has been researched along with Abdominal Neoplasms in 15 studies
Mitomycin: An antineoplastic antibiotic produced by Streptomyces caespitosus. It is one of the bi- or tri-functional ALKYLATING AGENTS causing cross-linking of DNA and inhibition of DNA synthesis.
mitomycin : A family of aziridine-containing natural products isolated from Streptomyces caespitosus or Streptomyces lavendulae.
Abdominal Neoplasms: New abnormal growth of tissue in the ABDOMEN.
Excerpt | Relevance | Reference |
---|---|---|
"Four patients suffering from malignant ascites were treated with the following method: peritoneal lavage and consequent injection of Mitomycin-C (20 mg/body surface m2) was performed for six hours via a catheter put into the peritoneal cavity according to Seldinger's method." | 4.78 | [First experiences with intraperitoneal chemotherapy]. ( Pikó, B; Vadon, G, 1991) |
"Based on a few previous studies, intra-peritoneal hyperthermic perfusion (IPHP) with Mitomycin C could become a beneficial treatment for peritoneal carcinomatosis." | 3.69 | [Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis]. ( Arnould, P; Bertrand, C; de Neve de Roden, A; Delvaux, P; Lechien, X; Mansvelt, B; Nockerman, P, 1997) |
"To treat carcinomatosis, we use cytoreductive surgery (CS) with hyperthermic intraperitoneal chemotherapy (HIPEC)." | 1.40 | Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients. ( Levine, EA; Loggie, BL; Russell, GB; Shen, P; Stewart, JH; Votanopoulos, KI, 2014) |
"The morbidity of abdominal and pelvic SFP performed on a miscellaneous group of patients in our institute was analyzed and potential risk factors for adverse events were evaluated." | 1.38 | Complications and toxicity after abdominal and pelvic hypoxic stop-flow perfusion chemotherapy: incidence and assessment of risk factors. ( Askoxylakis, J; de Bree, E; Melissas, J; Metaxari, M; Michalakis, J; Romanos, J; Tsiftsis, DD; Tsogkas, J; Volakakis, E, 2012) |
"A 60-year-old woman with gastric cancer had undergone partial gastrectomy in September 1989." | 1.28 | Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate. ( Hosokawa, T; Kajiwara, T; Ogawa, K; Otani, Y, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (13.33) | 18.7374 |
1990's | 6 (40.00) | 18.2507 |
2000's | 4 (26.67) | 29.6817 |
2010's | 3 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Levine, EA | 2 |
Stewart, JH | 2 |
Shen, P | 2 |
Russell, GB | 1 |
Loggie, BL | 1 |
Votanopoulos, KI | 2 |
Randle, RW | 1 |
Clark, CJ | 1 |
de Bree, E | 1 |
Romanos, J | 1 |
Tsogkas, J | 1 |
Askoxylakis, J | 1 |
Metaxari, M | 1 |
Michalakis, J | 1 |
Volakakis, E | 1 |
Melissas, J | 1 |
Tsiftsis, DD | 1 |
Chung, NC | 1 |
Liu, YC | 1 |
Ye, XD | 1 |
Wang, YM | 1 |
Kuo, MC | 1 |
Liu, K | 1 |
van IJken, MG | 1 |
de Bruijn, EA | 1 |
ten Hagen, TL | 1 |
de Boeck, G | 1 |
van Eijck, CH | 1 |
Eggermont, AM | 1 |
Hesdorffer, ME | 1 |
Chabot, JA | 1 |
Keohan, ML | 1 |
Fountain, K | 1 |
Talbot, S | 1 |
Gabay, M | 1 |
Valentin, C | 1 |
Lee, SM | 1 |
Taub, RN | 1 |
Sato, M | 1 |
Ishidoya, T | 1 |
Joko, Y | 1 |
Kiyasu, Y | 1 |
Sakai, K | 1 |
Kimura, S | 1 |
Mansvelt, B | 1 |
Bertrand, C | 1 |
Nockerman, P | 1 |
Arnould, P | 1 |
Delvaux, P | 1 |
Lechien, X | 1 |
de Neve de Roden, A | 1 |
Ben-Ari, GY | 1 |
Berkenstadt, H | 1 |
Ben-Ari, G | 2 |
Perel, A | 1 |
Scott, D | 1 |
Zippel, D | 1 |
Sareli, M | 1 |
Koller, M | 1 |
Papa, M | 1 |
Hosokawa, T | 1 |
Otani, Y | 1 |
Ogawa, K | 1 |
Kajiwara, T | 1 |
Muchmore, JH | 1 |
Krementz, ET | 1 |
Carter, RD | 1 |
Preslan, JE | 1 |
George, WJ | 1 |
Pikó, B | 1 |
Vadon, G | 1 |
Arai, Y | 1 |
Kido, C | 1 |
Ota, K | 1 |
Endo, T | 1 |
Suyama, K | 1 |
1 review available for mitomycin and Abdominal Neoplasms
Article | Year |
---|---|
[First experiences with intraperitoneal chemotherapy].
Topics: Abdominal Neoplasms; Antineoplastic Agents; Ascites; Follow-Up Studies; Humans; Injections, Intraper | 1991 |
1 trial available for mitomycin and Abdominal Neoplasms
Article | Year |
---|---|
Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.
Topics: Abdominal Neoplasms; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adju | 2008 |
13 other studies available for mitomycin and Abdominal Neoplasms
Article | Year |
---|---|
Intraperitoneal chemotherapy for peritoneal surface malignancy: experience with 1,000 patients.
Topics: Abdominal Neoplasms; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplast | 2014 |
Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for gallbladder cancer: a retrospective review.
Topics: Abdominal Cavity; Abdominal Neoplasms; Adenocarcinoma; Adult; Antineoplastic Agents; Chemotherapy, C | 2014 |
Complications and toxicity after abdominal and pelvic hypoxic stop-flow perfusion chemotherapy: incidence and assessment of risk factors.
Topics: Abdominal Neoplasms; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; | 2012 |
Fatal arrhythmia following intraoperative continuous hyperthermic peritoneal perfusion chemotherapy.
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Chemotherapy, | 2003 |
Balloon catheter hypoxic abdominal and pelvic perfusion with tumour necrosis factor-alpha, Melphalan and Mitomycin C: a pharmacokinetic study in pigs.
Topics: Abdominal Neoplasms; Animals; Antineoplastic Agents; Balloon Occlusion; Chemotherapy, Cancer, Region | 2004 |
[Constant intra-aortic infusion chemotherapy for advanced abdominal cancer--a technic and the effect in patients with peritoneal metastases].
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Coloni | 1984 |
[Study of the toxicity and results of intraperitoneal hyperthermic chemotherapy in 28 patients with peritoneal carcinomatosis].
Topics: Abdominal Neoplasms; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Female; Humans; Hyperther | 1997 |
Treatment of abdominal malignancies using total abdominal stop-flow infusion and hypoxic perfusion.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, | 1997 |
Hemodynamic changes during a new procedure for regional chemotherapy involving occlusion of the thoracic aorta and inferior vena cava.
Topics: Abdominal Neoplasms; Adult; Aged; Anesthesia, General; Antibiotics, Antineoplastic; Antimetabolites, | 1998 |
Continuous hyperthermic peritoneal perfusion (CHPP) for malignant ascites and irresectable intra-abdominal cancer.
Topics: Abdominal Neoplasms; Antineoplastic Combined Chemotherapy Protocols; Ascites; Cell Division; Cisplat | 2000 |
Complete disappearance of metastatic abdominal tumors from gastric cancer after treatment with irsogladine maleate.
Topics: Abdominal Neoplasms; Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Pro | 1992 |
Treatment of abdominal malignant neoplasms using regional chemotherapy with hemofiltration.
Topics: Abdominal Neoplasms; Adult; Aged; Clinical Protocols; Combined Modality Therapy; Female; Hemofiltrat | 1991 |
[Intra-arterial infusion chemotherapy using a subcutaneously implanted silicone reservoir--with reference to the chemotherapy protocol].
Topics: Abdominal Neoplasms; Aged; Antineoplastic Combined Chemotherapy Protocols; Catheterization; Cytarabi | 1985 |